Pyrovalerone: Difference between revisions
CSV import |
CSV import |
||
| (2 intermediate revisions by the same user not shown) | |||
| Line 1: | Line 1: | ||
{{Short description|A psychoactive drug used as a stimulant}} | |||
'''Pyrovalerone''' is a [[psychoactive drug]] that acts as a [[stimulant]] and is used in the treatment of chronic [[fatigue]] and as an [[anorectic]]. It is a member of the [[cathinone]] class of drugs and is chemically related to other stimulants such as [[methcathinone]] and [[mephedrone]]. | |||
[[Pyrovalerone]] | ==Chemical Structure and Properties== | ||
[[File:Pyrovalerone.svg|Chemical structure of Pyrovalerone|thumb|right]] | |||
Pyrovalerone is a synthetic compound with the chemical formula C16H21NO. It is structurally characterized by a pyrrolidine ring attached to a valerophenone backbone. The presence of the pyrrolidine ring is a common feature in many stimulant drugs, contributing to their psychoactive properties. | |||
== Pharmacology == | ==Pharmacology== | ||
Pyrovalerone functions primarily as a [[norepinephrine-dopamine reuptake inhibitor]] (NDRI). This means it increases the levels of the neurotransmitters [[norepinephrine]] and [[dopamine]] in the brain by inhibiting their reuptake into neurons. This action results in increased alertness, energy, and a sense of well-being, which are characteristic effects of stimulant drugs. | |||
==Medical Uses== | |||
Pyrovalerone has been used clinically to treat conditions such as chronic fatigue and as an appetite suppressant. However, its use is limited due to the potential for abuse and the development of dependence. It is not commonly prescribed today, as safer alternatives are available. | |||
== | ==Side Effects and Risks== | ||
The use of pyrovalerone can lead to a range of side effects, including increased heart rate, elevated blood pressure, anxiety, and insomnia. Long-term use can result in psychological dependence and withdrawal symptoms upon cessation. Due to these risks, pyrovalerone is classified as a controlled substance in many countries. | |||
==Legal Status== | |||
Pyrovalerone is classified as a Schedule V controlled substance in the United States under the [[Controlled Substances Act]]. This classification indicates that it has a lower potential for abuse compared to drugs in Schedules I-IV, but it still requires regulation and control. | |||
== | ==Related Compounds== | ||
Pyrovalerone is chemically related to other stimulants such as [[methylphenidate]] and [[cocaine]]. These compounds share similar mechanisms of action but differ in their potency, duration of action, and side effect profiles. | |||
==Research and Development== | |||
Research into pyrovalerone and its analogs continues, particularly in the context of understanding their pharmacological effects and potential therapeutic applications. However, the focus is often on developing safer alternatives with reduced abuse potential. | |||
==Related Pages== | |||
* [[Stimulant]] | * [[Stimulant]] | ||
* [[ | * [[Norepinephrine-dopamine reuptake inhibitor]] | ||
* [[Controlled Substances Act]] | * [[Controlled Substances Act]] | ||
* [[Cathinone]] | |||
[[File:Pyrovalerone3d.png|3D model of Pyrovalerone|thumb|left]] | |||
[[Category:Stimulants]] | [[Category:Stimulants]] | ||
[[Category:Cathinones]] | |||
[[Category:Controlled substances]] | [[Category:Controlled substances]] | ||
Latest revision as of 11:38, 23 March 2025
A psychoactive drug used as a stimulant
Pyrovalerone is a psychoactive drug that acts as a stimulant and is used in the treatment of chronic fatigue and as an anorectic. It is a member of the cathinone class of drugs and is chemically related to other stimulants such as methcathinone and mephedrone.
Chemical Structure and Properties[edit]
Pyrovalerone is a synthetic compound with the chemical formula C16H21NO. It is structurally characterized by a pyrrolidine ring attached to a valerophenone backbone. The presence of the pyrrolidine ring is a common feature in many stimulant drugs, contributing to their psychoactive properties.
Pharmacology[edit]
Pyrovalerone functions primarily as a norepinephrine-dopamine reuptake inhibitor (NDRI). This means it increases the levels of the neurotransmitters norepinephrine and dopamine in the brain by inhibiting their reuptake into neurons. This action results in increased alertness, energy, and a sense of well-being, which are characteristic effects of stimulant drugs.
Medical Uses[edit]
Pyrovalerone has been used clinically to treat conditions such as chronic fatigue and as an appetite suppressant. However, its use is limited due to the potential for abuse and the development of dependence. It is not commonly prescribed today, as safer alternatives are available.
Side Effects and Risks[edit]
The use of pyrovalerone can lead to a range of side effects, including increased heart rate, elevated blood pressure, anxiety, and insomnia. Long-term use can result in psychological dependence and withdrawal symptoms upon cessation. Due to these risks, pyrovalerone is classified as a controlled substance in many countries.
Legal Status[edit]
Pyrovalerone is classified as a Schedule V controlled substance in the United States under the Controlled Substances Act. This classification indicates that it has a lower potential for abuse compared to drugs in Schedules I-IV, but it still requires regulation and control.
Related Compounds[edit]
Pyrovalerone is chemically related to other stimulants such as methylphenidate and cocaine. These compounds share similar mechanisms of action but differ in their potency, duration of action, and side effect profiles.
Research and Development[edit]
Research into pyrovalerone and its analogs continues, particularly in the context of understanding their pharmacological effects and potential therapeutic applications. However, the focus is often on developing safer alternatives with reduced abuse potential.
Related Pages[edit]
